Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 8,430.00
+240.00 (2.93%)
Mar 20, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 609.84 billion as of March 20, 2026. Its market cap has increased by 110.09% in one year.
Market Cap
609.84B
Enterprise Value
625.31B
Revenue
56.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,430.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 609.84B, an increase of 546.97%. That is a compound annual growth rate of 8.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 609.84B | 20.30% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.27T |
| Celltrion | 45.86T |
| ALTEOGEN | 18.99T |
| Sam Chun Dang Pharm. | 18.23T |
| Dong-A Socio Holdings | 688.73B |
| Curexo | 671.82B |
| Green Cross Holdings | 639.71B |
| WON TECH | 634.25B |